CAS 2031161-35-8

Formel: C20H15F4N3O2

InChl: InChI=1S/C20H15F4N3O2/c1-19(29,11-27-7-6-12-8-14(21)3-5-17(12)27)18(28)26-15-4-2-13(10-25)16(9-15)20(22,23)24/h2-9,29H,11H2,1H3,(H,26,28)/t19-/m0/s1

InChI Key: CFSAYQVTXBMPRF-IBGZPJMESA-N

SMILES: C[C@](CN1C=CC2=C1C=CC(=C2)F)(C(=O)NC3=CC(=C(C=C3)C#N)C(F)(F)F)O

UT-155

CAS: 2031161-35-8

UT-155

Formel: C₂₀H₁₅F₄N₃O₂

Reinheit: ≥98%

Molekulargewicht: 405.35

Ref: 54-BUP08922

UT-155

CAS: 2031161-35-8

UT-155 is a selective and potent antagonist of the androgen receptor (AR) (Ki: 267 nM for UT-155 binding to AR-LBD).

Formel: C₂₀H₁₅F₄N₃O₂

Reinheit: 98.94%

Farbe und Form: White Solid

Molekulargewicht: 405.3456

Ref: TM-T13272

UT-155

CAS: 2031161-35-8

Formel: C₂₀H₁₅F₄N₃O₂

Reinheit: 99.39%

Molekulargewicht: 405.3456

Ref: IN-DA01EO6H

UT-155

CAS: 2031161-35-8

(S)-N-(4-Cyano-3-(trifluoromethyl)phenyl)-3-(5-fluoro-1H-indol-1-yl)-2-hydroxy-2-methylpropanamide

Formel: C₂₀H₁₅F₄N₃O₂

Reinheit: 99.39%

Molekulargewicht: 405.35

Ref: IN-DG01112028

UT-155

CAS: 2031161-35-8

UT-155 is a monoclonal antibody that binds to the ubiquitin-proteasome receptor. It is used in research to study the mechanism of ubiquitin-proteasome function in cells. UT-155 has been shown to inhibit prostate cancer cells and leukemia cells, as well as reduce tumor size in mice with prostate cancer. This drug also inhibits the production of ferroptosis and splicing, which are pro-apoptotic processes.

Formel: C₂₀H₁₅F₄N₃O₂

Reinheit: Min. 95%

Molekulargewicht: 405.3 g/mol

Ref: 3D-GGD16135